Drug Trial Radar · NCT07287644
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
210
Planned (sponsor's estimate)
Start
Nov 3, 2025
Primary completion
Aug 1, 2027
Study completion Aug 1, 2027
Sponsor
- Lead sponsor
- Bluefin Biomedicine, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.
Conditions
- Hidradenitis Suppurativa (HS)
Interventions
BFB759Biological
BFB759 is a human mAb that inhibits multiple pro-inflammatory cytokines that contribute to the pathogenesis of multiple disease processes characterized by aberrant inflammation, including hidradenitis suppurativa.
Placebo for BFB759Other
Placebo for BFB759
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy of BFB759 in HSTime frame: Baseline to Week 16 and baseline to Week 32
Locations
64 sites in 7 countries. Site status is shown where the registry gives one.
Saguaro Dermatology
Phoenix, Arizona
Encino Research Center
Encino, California
Marvel Clinical Research LLC
Huntington Beach, California
Clinical Science Institute
Santa Monica, California
Skin Care Research
Boca Raton, Florida
Center for Skin Science and Innovation
Fort Lauderdale, Florida
Gsi Clinical Research
Margate, Florida
Ziaderm Research LLC
North Miami Beach, Florida
Clinical Trials Management, LLC
Tampa, Florida
DelRicht Research
Atlanta, Georgia
Southeast Research Specialist LLC
Douglasville, Georgia
The Indiana Clinical Trials Center, PC
Plainfield, Indiana
DS Research of Kentucky
Louisville, Kentucky
Martha Stewart
Mandeville, Louisiana
Clinical Trials Management, LLC
Metairie, Louisiana
DelRicht Research
New Orleans, Louisiana
Oakland Hills Dermatology
Auburn Hills, Michigan
MI Skin Innovations
Northville, Michigan
DelRicht Research
Wildwood, Missouri
JDR Dermatology Research LLC
Las Vegas, Nevada
Skin Cancer and Dermatology Institute
Reno, Nevada
Schweiger Dermatology, PC
Hackensack, New Jersey
Equity Medical LLC
The Bronx, New York
Optima Research - Boardman
Boardman, Ohio
Apex Clinical Research Center, LLC
Canton, Ohio
Apex Clinical Research Center, LLC
Mayfield Heights, Ohio
UPMC Department of Dermatology
Pittsburgh, Pennsylvania
Medical Univ of SC Department of Dermatology
Charleston, South Carolina
DelRicht Research
Mt. Pleasant, South Carolina
DelRicht Research
Smyrna, Tennessee
Dermatology Treatment & Research Center
Dallas, Texas
VAST Clinical Research LLC
Frisco, Texas
DelRicht Research
Prosper, Texas
Stryde Research-Epiphany Dermatology
Southlake, Texas
Dermatology Specialists of Spokane
Spokane, Washington
Medical Center Medconsult Burgas EOOD
Burgas, Bulgaria
Medical Center Medconsult Pleven-Lovech Branch
Lovech, Bulgaria
Medical Center Medconsult Pleven OOD
Pleven, Bulgaria
Medical Center Etika Ambulatory For Specialized Outpatient Medical Care OOD
Plovdiv, Bulgaria
Medical Center Rusemed
Rousse, Bulgaria
Showing 40 of 64 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.